Segment Information (Tables)

12 Months Ended

Dec. 31, 2017

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated [Table Text Block]

Information regarding the Company’s segments for the year ended December 31, 2017 and 2016 is as follows:

Revenues by segment	Year Ended
	December 31,
(in thousands)	2017		2016
Income Generating Assets	$	235,937	$	212,632
Pharmaceutical	69,032		31,669
Medical Devices	15,091		—
Total revenues	$	320,060	$	244,301

Net income (net loss) by segment	Year Ended
	December 31,
(in thousands)	2017			2016
Income Generating Assets	$	125,759		$	59,085
Pharmaceutical	(5,755		)	4,521
Medical Devices	(9,256		)	—
Total net income	$	110,748		$	63,606

Long-lived assets by segment	Year Ended
	December 31,
(in thousands)	2017		2016
Income Generating Assets	$	137	$	38
Pharmaceutical	822		—
Medical Devices	6,263		—
Total long-lived assets	$	7,222	$	38

The operations for the Company’s Pharmaceutical and Medical Devices segments are primarily located in Ireland and the United States, respectively.